NVO catalyst calendar
Clinical trials led by listed companies, by the completion date the sponsor registered on ClinicalTrials.gov, soonest first, from today. Most future dates are the sponsor's estimate and can move.
Windows longer than 90 days are part of TrialScanner, so this list covers the next 90 days.
November 2026
| Primary completion | Trial | Company and role | Phase | Status | Enrollment | Interventions | Completion |
|---|---|---|---|---|---|---|---|
| Nov 30, 2026Sponsor estimate | NCT05689372Regulatory Post Marketing Surveillance (rPMS) Study of Ozempic (Semaglutide) to Evaluate Safety and Effectiveness in Patients With Type...Novo Nordisk A/S · Diabetes Mellitus, Type 2 | NVOLead | No phase registered | Enrolling by invitation | Locked | Locked | Locked |
- Primary completion Nov 30, 2026Sponsor estimateNo phase registeredNCT05689372Regulatory Post Marketing Surveillance (rPMS) Study of Ozempic (Semaglutide) to Evaluate Safety and Effectiveness in Patients With Type...Novo Nordisk A/S · Diabetes Mellitus, Type 2Enrolling by invitationNVOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
December 2026
| Primary completion | Trial | Company and role | Phase | Status | Enrollment | Interventions | Completion |
|---|---|---|---|---|---|---|---|
| Dec 1, 2026Sponsor estimate | NCT04682145Adverse Event Data Collection From the EUHASS Registry on Turoctocog Alfa PegolNovo Nordisk A/S · Haemophilia A | NVOLead | No phase registered | Enrolling by invitation | Locked | Locked | Locked |
| Dec 26, 2026Sponsor estimate | NCT07653139Patient Preferences in Treatment of Haemophilia A With and Without Inhibitors: a Discrete Choice Experiment in GermanyNovo Nordisk A/S · Haemophilia A | NVOLead | No phase registered | Enrolling by invitation | Locked | Locked | Locked |
| Dec 31, 2026Sponsor estimate | NCT07713901Database Linkage Study to Evaluate the Risk of Medullary Thyroid CarcinomaNovo Nordisk A/S · Medullary Thyroid Carcinoma | NVOLead | No phase registered | Enrolling by invitation | Locked | Locked | Locked |
- Primary completion Dec 1, 2026Sponsor estimateNo phase registeredNCT04682145Adverse Event Data Collection From the EUHASS Registry on Turoctocog Alfa PegolNovo Nordisk A/S · Haemophilia AEnrolling by invitationNVOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 26, 2026Sponsor estimateNo phase registeredNCT07653139Patient Preferences in Treatment of Haemophilia A With and Without Inhibitors: a Discrete Choice Experiment in GermanyNovo Nordisk A/S · Haemophilia AEnrolling by invitationNVOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 31, 2026Sponsor estimateNo phase registeredNCT07713901Database Linkage Study to Evaluate the Risk of Medullary Thyroid CarcinomaNovo Nordisk A/S · Medullary Thyroid CarcinomaEnrolling by invitationNVOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 4 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScannerHow to read this calendar
Completion dates as registered on ClinicalTrials.gov by the sponsor, for trials Signal8 links to a listed company. Most future dates are the sponsor's estimate and move. A completion date is when the last participant is measured, not when results are announced.
The window starts today. A date the sponsor registered to the day is listed when it falls inside the window; a date that has already passed is never listed as upcoming, even when the sponsor has not updated it yet. A date registered to the month only (shown as, say, Dec 2026) could be any day of that month, so it is listed only when the whole month falls inside the window. TrialScanner never adds a day the sponsor did not register.
By default the list shows trials where a listed company is the lead sponsor. Trials a listed company only collaborates on (as a partner, drug supplier or contract research organization) are added with the role filter, and every company is labelled Lead or Collaborator.
Free readers see the first 25 trials of any filter and windows up to 90 days, with the trial, phase, status, sponsor and primary completion. Enrollment, interventions, the start and completion dates, longer windows and later pages are part of the plan. See the methodology.